Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Use of Opioid Agonist Therapy for Medicare Patients in 2013

Use of Opioid Agonist Therapy for Medicare Patients in 2013 This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Psychiatry American Medical Association

Use of Opioid Agonist Therapy for Medicare Patients in 2013

JAMA Psychiatry , Volume 73 (9) – Sep 20, 2016

Loading next page...
 
/lp/american-medical-association/use-of-opioid-agonist-therapy-for-medicare-patients-in-2013-yBPUtNH8IN
Publisher
American Medical Association
Copyright
Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-622X
eISSN
2168-6238
DOI
10.1001/jamapsychiatry.2016.1390
pmid
27438334
Publisher site
See Article on Publisher Site

Abstract

This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013.

Journal

JAMA PsychiatryAmerican Medical Association

Published: Sep 20, 2016

References